Clarke Atwell is the founder of Claris Biotherapeutics. Claris Biotherapeutics has raised $57M in total funding. Latest round: Series A.
Clarke Atwell is the founding CEO and President of Claris Biotherapeutics, a late-clinical stage biotechnology company focused on developing topical ophthalmic biologics for corneal diseases. He is a biopharma veteran with over 20 years of experience founding and leading ophthalmology-focused companies. Under his leadership, Claris emerged from stealth in January 2024 with $57 million in Series A funding.
Full founder directory · Investor directory · Company funding database · Fundraising library